ABCA3 and interstitial lung disease: Moreover, heterozygous ABCA3 mutations have been described in combination with SFTPC mutations in infants with ILD, suggesting that the gene might be acting as a modifier of the disease severity in individuals with SFTPC mutations (66, 89).